eleva GmbH

General information
eleva GmbH
Hans-Bunte-Str. 19
79108 Freiburg, Baden-W├╝rttemberg
Germany

Contact person: Jana Gross, Director Business Development
Company main phone: +49 (761) 470990
Company main fax:  +49 (761) 47099191
Website:  https://www.elevabiologics.com
Year founded:1999
Source of foundation:Independent foundation
No. of employees: Worldwide:  30
Corporate description / mission:
eleva GmbH develops biological therapies with its pharmaceutical partners. The privately-held company leverages its unique moss-based production platform to produce antibodies, replacement enzymes, and fusion toxins. Eleva has successfully developed drug candidates into clinical phases.
State of ownership: Private / independent
Headquarters: HQ: Yes
Remarks on ownership / listings
Previously known as Greenovation Biotech GmbH
Categorization
Sector:
  • Biotechnology - Therapeutics and Diagnostics
Subsector:
  • Antibodies
  • Antibody-drug-conjugate
  • Proteins
Primary therapeutic areas:
  • Diseases of the blood and blood-forming organs & immune disorders / hematology / immunology
  • Endocrine, nutritional and metabolic diseases / endocrinology
  • Genitourinary system / Urology
  • Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
Business model:
  • Out-licensing
  • R&D
  • Research on contract basis
Customer segments:
  • Large biotech & big pharma
  • Small biotech
Summary Products / Services / Technologies
Number of Biotech Products
Pre-clinical:4
Phase I:1
Description of products:
Compleva FH /CPV-104
Compleva MFHR1/CPV-102
Repleva AGAL/RPV-001, etc.
X